We don't follow trends; we architect the future.
At Symbio Holdings, we solve complex, systemic problems by creating foundational technologies where human expertise and machine intelligence work together, symbiotically.
Our goal: faster insight, better decisions, and scalable solutions across the industries that matter most.
Interactive platform ecosystem
Where human expertise meets machine intelligence
Modular enterprise application platform enabling rapid transformation of concepts into professional-grade, regulatory compliant applications.
Transforms high-level objectives into executable simulations, enabling organizations to explore scenarios, stress-test strategies, and understand causal system behavior.
Robust multi-agent operating system to build, manage, and orchestrate framework agnostic autonomous agentic workflows at enterprise scale.
Agent-first marketplace for single-purpose, high-utility micro-APIs with built-in discovery, usage tracking, and credit-based payments.
Enterprise Multi-agent AI operating system for pharma research and development workflow automation. End-to-end from discovery to commercialization.
Intelligent Integrated Evidence Planning solution with regulatory intelligence for drug life cycle management and gap analysis.
AI-powered systematic literature review for the pharmaceutical industry optimized for compliance, accuracy, and pharma-specific workflows.
Enterprise platform for radiopharmaceutical development. Deep research, validation, molecular generation, and in-silico development.
Core platforms and specialized solutions working together to transform healthcare, science, and enterprise.
Modular platform enabling rapid transformation of concepts into professional-grade, regulatory compliant applications. SOC2, HIPAA, GDPR, 21CFR11, ISO compliant.
Transforms high-level objectives into executable simulations, enabling organizations to explore scenarios, stress-test strategies, and understand causal system behavior before committing real-world resources.
Robust multi-agent operating system to build, manage, and orchestrate framework-agnostic autonomous agentic workflows at enterprise scale.
Agent-first marketplace for single-purpose, high-utility micro-APIs with built-in discovery, usage tracking, and credit-based payments.
Enterprise multi-agent AI operating system for pharma research and development workflow automation. End-to-end from discovery to commercialization.
Intelligent Integrated Evidence Planning solution with regulatory intelligence for drug life cycle management and gap analysis.
AI-powered systematic literature review for the pharmaceutical industry optimized for compliance, accuracy, and pharma-specific workflows.
Enterprise platform for radiopharmaceutical development. Deep research, validation, molecular generation, and in-silico development.
We solve problems from the ground up, not with off-the-shelf frameworks.
Every product is interoperable, scalable, and designed for long-term extensibility.
We embed regulatory standards directly into our platforms.
Our platforms bring humans and machines into productive collaboration, not competition.
Symbio Holdings was founded by engineers, scientists, and operators who believe in designing the systems that will underpin the next generation of discovery, care, and decision-making. We've built for startups and Fortune 100s alike and now we're focused on building what doesn't exist yet.
Want to collaborate, invest, or explore partnership?
We're selective but open to conversations that matter.